New drug 'staves off' Alzheimer's symptoms

Dublin : Ireland | Oct 10, 2012 at 1:50 AM PDT

Source: Independent

XX XX

Views: Pending

Wednesday October 10 2012 A NEW drug could dramatically slow the onset of memory loss for people with Alzheimer's disease. Combined results from two trials showed that the drug, called solanezumab, slowed the speed of mental decline by a third in those with mild-to-moderate cases of the disease. FULL ARTICLE AT Independent

1 of 1

Alzheimer's disease

Credibility
Reach

More News From: Dublin : Ireland

News Stories

Roche partners on hearing-loss drug

Suburban Trends

The drug maker said it has entered into an exclusive partnership with Versant Ventures and Inception Sciences to create a drug discovery incubator, Inception 3, for the treatment of sensorineural hearing loss. It is the most common type of permanent...
Roche, Lilly drugs set for Alzheimer's prevention trial

Turks and Caicos Free Press

A logo of Swiss pharmaceutical company Roche is pictured in front of a company's building in Rotkreuz, April 12, 2012. Experimental Alzheimer's drugs from Roche Holding AG and Eli Lilly & Co have been selected for a high-profile clinical trial to...
Roche, Lilly drugs chosen for Alzheimer's trial

Reuters

Topics A logo of Swiss pharmaceutical company Roche is pictured in front of a company's building in Rotkreuz, April 12, 2012. Experimental drugs from Roche Holding AG and Eli Lilly & Co have been selected for a global Alzheimer's disease prevention...
Eli Lilly announces phase 3 Solanezumab EXPEDITION studies results

Pharmaceutical Industry News

Rachelle Doody said, "These results represent an important step for the medical, academic, and scientific communities in understanding brain amyloid as a target of AD therapies."...In Lilly's pre-specified secondary analysis of pooled data in...